The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
Portfolio Pulse from Benzinga Insights
Cardlytics (NASDAQ:CDLX) has received varied analyst ratings over the past quarter, with a recent shift towards a more bullish outlook. The average 12-month price target for CDLX has increased by 28.0% to $16.00, with high and low estimates of $18.00 and $12.00, respectively. Analysts from Needham, Lake Street, and Craig-Hallum have raised their price targets, reflecting optimism about the company's performance. Cardlytics operates an advertising platform within financial institutions and has shown a revenue growth rate of 8.08% as of December 31, 2023. However, the company faces challenges with a net margin of -113.09%, ROE of -56.0%, ROA of -16.68%, and a high debt-to-equity ratio of 1.97.
April 09, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cardlytics has seen a positive shift in analyst ratings, with an increased average 12-month price target to $16.00. Despite revenue growth, the company struggles with profitability and high debt.
The increase in the average 12-month price target and the recent bullish ratings from analysts suggest a positive short-term outlook for CDLX. However, the company's financial challenges, such as negative net margin and high debt, may temper the potential stock price growth. The analysis considers the recent positive analyst sentiment and the company's operational and financial metrics.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100